Rxo (RXO) Change in Cash (2021 - 2026)

Rxo (RXO) has 6 years of Change in Cash data on file, last reported at $4.0 million in Q1 2026.

• Quarterly Change in Cash rose 121.05% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 33.33% YoY) and the FY2025 annual result came in at -$17.0 million, down 156.67% from the prior year.
• Change in Cash improved to $4.0 million in Q1 2026, from -$8.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $166.0 million in Q2 2022 to a low of -$99.0 million in Q4 2023.
• A 5-year average of -$437500.0 and a median of $2.5 million in 2023 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash tumbled 4350.0% — and 2024, when it surged 340.0%.
• Tracing RXO's Change in Cash over 5 years: stood at -$89.0 million in 2022, then slipped by 11.24% to -$99.0 million in 2023, then surged by 79.8% to -$20.0 million in 2024, then soared by 60.0% to -$8.0 million in 2025, then soared by 150.0% to $4.0 million in 2026.
• The last three Change in Cash figures came in at $4.0 million (Q1 2026), -$8.0 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.